Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph; Extension of Comment Period; Correction

---
identifier: "/us/fr/03-25044"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph; Extension of Comment Period; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "03-25044"
section_name: "Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph; Extension of Comment Period; Correction"
positive_law: false
currency: "2003-10-06"
last_updated: "2003-10-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-25044"
document_type: "proposed_rule"
publication_date: "2003-10-06"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 356"
fr_citation: "68 FR 57642"
fr_volume: 68
docket_ids:
  - "Docket No. 81N-033P"
comments_close_date: "2003-11-25"
fr_action: "Advance notice of proposed rulemaking; extension of comment period; correction."
---


#  Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph; Extension of Comment Period; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Advance notice of proposed rulemaking; extension of comment period; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a document that appeared in the *Federal Register* of August 25, 2003 (68 FR 50991). The document announced that FDA extended to November 25, 2003, the comment period for an advance notice of proposed rulemaking (ANPR) for over-the-counter antigingivitis/antiplaque drug products. The ANPR was published in the *Federal Register* of May 29, 2003 (68 FR 32232). The document published with an inadvertent error. This document corrects that error.

**DATES:**

Submit written or electronic comments by November 25, 2003. Submit reply comments by February 23, 2004.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy and Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 03-21669, appearing on page 50992 in the *Federal Register* of August 25, 2003, the following correction is made:

1. On page 50992, in the second column, under *IV. Comments* , in the sixth line, “two” is corrected to read “three”.

Dated:  September 25, 2003.

Jeffrey Shuren,

Assistant Commissioner for Policy.